

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.21128544 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.21128544 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.99330851 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.75172457 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.75172457 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.75172457 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.75172457 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.75172457 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 5.75172457 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.69539367 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.66599038 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.65236560 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 5.27071364 |
| 14 | detection of other organism (GO:0098543) | 5.25155960 |
| 15 | leukocyte aggregation (GO:0070486) | 5.18873069 |
| 16 | detection of bacterium (GO:0016045) | 5.17803797 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.07775258 |
| 18 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.66913600 |
| 19 | plasma membrane repair (GO:0001778) | 4.64489524 |
| 20 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.57080081 |
| 21 | response to peptidoglycan (GO:0032494) | 4.51581918 |
| 22 | macrophage activation involved in immune response (GO:0002281) | 4.50071656 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.48852504 |
| 24 | detection of external biotic stimulus (GO:0098581) | 4.26230880 |
| 25 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.20881463 |
| 26 | respiratory burst (GO:0045730) | 4.20682498 |
| 27 | synaptic vesicle maturation (GO:0016188) | 4.20595757 |
| 28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.17150863 |
| 29 | response to interleukin-15 (GO:0070672) | 3.99480293 |
| 30 | regulation of gamma-delta T cell activation (GO:0046643) | 3.99406411 |
| 31 | cellular extravasation (GO:0045123) | 3.98515394 |
| 32 | neutrophil activation (GO:0042119) | 3.98350093 |
| 33 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.97200279 |
| 34 | response to host immune response (GO:0052572) | 3.97200279 |
| 35 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.96153601 |
| 36 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.90912573 |
| 37 | regulation of mast cell degranulation (GO:0043304) | 3.90897725 |
| 38 | immunoglobulin mediated immune response (GO:0016064) | 3.80756218 |
| 39 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.80621061 |
| 40 | detection of temperature stimulus (GO:0016048) | 3.78973372 |
| 41 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.76426985 |
| 42 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.76426985 |
| 43 | detection of biotic stimulus (GO:0009595) | 3.75435032 |
| 44 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.72773395 |
| 45 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.71572056 |
| 46 | response to host (GO:0075136) | 3.71572056 |
| 47 | response to host defenses (GO:0052200) | 3.71572056 |
| 48 | proline transport (GO:0015824) | 3.71086139 |
| 49 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.70654539 |
| 50 | detection of molecule of bacterial origin (GO:0032490) | 3.66168158 |
| 51 | cell communication by electrical coupling (GO:0010644) | 3.65231708 |
| 52 | negative regulation of microtubule polymerization (GO:0031115) | 3.64115166 |
| 53 | negative regulation of phagocytosis (GO:0050765) | 3.63471937 |
| 54 | negative regulation of cell size (GO:0045792) | 3.60231388 |
| 55 | regulation of leukocyte degranulation (GO:0043300) | 3.57021850 |
| 56 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.56680690 |
| 57 | granulocyte activation (GO:0036230) | 3.55446332 |
| 58 | activation of protein kinase A activity (GO:0034199) | 3.52821772 |
| 59 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.50273838 |
| 60 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.49997309 |
| 61 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.49848325 |
| 62 | negative regulation of interleukin-12 production (GO:0032695) | 3.48668693 |
| 63 | B cell receptor signaling pathway (GO:0050853) | 3.47392029 |
| 64 | cellular response to interleukin-15 (GO:0071350) | 3.47267347 |
| 65 | response to muramyl dipeptide (GO:0032495) | 3.47128319 |
| 66 | cell communication involved in cardiac conduction (GO:0086065) | 3.46867333 |
| 67 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.41518376 |
| 68 | sodium ion export (GO:0071436) | 3.40432287 |
| 69 | alanine transport (GO:0032328) | 3.37884942 |
| 70 | positive thymic T cell selection (GO:0045059) | 3.37555578 |
| 71 | myeloid cell activation involved in immune response (GO:0002275) | 3.34807439 |
| 72 | positive regulation of B cell differentiation (GO:0045579) | 3.33606399 |
| 73 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.30284057 |
| 74 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.30066981 |
| 75 | regulation of B cell differentiation (GO:0045577) | 3.28517119 |
| 76 | tricarboxylic acid cycle (GO:0006099) | 3.28275316 |
| 77 | negative thymic T cell selection (GO:0045060) | 3.27278362 |
| 78 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.26305205 |
| 79 | barbed-end actin filament capping (GO:0051016) | 3.23871549 |
| 80 | regulation of early endosome to late endosome transport (GO:2000641) | 3.23349000 |
| 81 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.22490458 |
| 82 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.22318689 |
| 83 | carnitine shuttle (GO:0006853) | 3.21751803 |
| 84 | cellular response to type I interferon (GO:0071357) | 3.21221193 |
| 85 | type I interferon signaling pathway (GO:0060337) | 3.21221193 |
| 86 | macrophage activation (GO:0042116) | 3.19836632 |
| 87 | response to type I interferon (GO:0034340) | 3.17993686 |
| 88 | regulation of regulated secretory pathway (GO:1903305) | 3.17931962 |
| 89 | cell migration in hindbrain (GO:0021535) | 3.17891234 |
| 90 | negative regulation of T cell mediated immunity (GO:0002710) | 3.16314396 |
| 91 | germinal center formation (GO:0002467) | 3.16050782 |
| 92 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.11989770 |
| 93 | negative T cell selection (GO:0043383) | 3.11886536 |
| 94 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.11863545 |
| 95 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.08934976 |
| 96 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.08138856 |
| 97 | microglial cell activation (GO:0001774) | 3.07278271 |
| 98 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.06841379 |
| 99 | positive regulation of mast cell activation (GO:0033005) | 3.05601277 |
| 100 | regulation of T cell tolerance induction (GO:0002664) | 3.04660919 |
| 101 | thymic T cell selection (GO:0045061) | 3.04626398 |
| 102 | negative regulation of type 2 immune response (GO:0002829) | 3.04286154 |
| 103 | neutrophil mediated immunity (GO:0002446) | 3.03938195 |
| 104 | glutamate secretion (GO:0014047) | 3.03113823 |
| 105 | leukocyte degranulation (GO:0043299) | 3.03047814 |
| 106 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.02624213 |
| 107 | fatty acid transmembrane transport (GO:1902001) | 2.98997979 |
| 108 | regulation of synapse structural plasticity (GO:0051823) | 2.98969697 |
| 109 | T cell selection (GO:0045058) | 2.97768964 |
| 110 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.97154507 |
| 111 | negative regulation of innate immune response (GO:0045824) | 2.96531264 |
| 112 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.95753815 |
| 113 | protein targeting to plasma membrane (GO:0072661) | 2.95473853 |
| 114 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.95289327 |
| 115 | regulation of tolerance induction (GO:0002643) | 2.94757546 |
| 116 | defense response to protozoan (GO:0042832) | 2.94240886 |
| 117 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.93433531 |
| 118 | positive regulation of axon extension (GO:0045773) | 2.93077385 |
| 119 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.91948075 |
| 120 | regulation of mast cell activation (GO:0033003) | 2.91330511 |
| 121 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.90220065 |
| 122 | B cell mediated immunity (GO:0019724) | 2.89879089 |
| 123 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.88400218 |
| 124 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.84414680 |
| 125 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.81147477 |
| 126 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.80926938 |
| 127 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.80926938 |
| 128 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.80637346 |
| 129 | tolerance induction (GO:0002507) | 2.80322557 |
| 130 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.79804872 |
| 131 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.79315426 |
| 132 | positive regulation of mast cell degranulation (GO:0043306) | 2.79315426 |
| 133 | regulation of translational termination (GO:0006449) | 2.78155778 |
| 134 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.77609138 |
| 135 | axon cargo transport (GO:0008088) | 2.77020793 |
| 136 | layer formation in cerebral cortex (GO:0021819) | 2.75849303 |
| 137 | negative regulation of interleukin-6 production (GO:0032715) | 2.75706740 |
| 138 | lysine metabolic process (GO:0006553) | 2.75204660 |
| 139 | lysine catabolic process (GO:0006554) | 2.75204660 |
| 140 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.74418870 |
| 141 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.73964022 |
| 142 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.73838148 |
| 143 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.73838148 |
| 144 | COPI coating of Golgi vesicle (GO:0048205) | 2.73128583 |
| 145 | Golgi transport vesicle coating (GO:0048200) | 2.73128583 |
| 146 | regulation of fatty acid oxidation (GO:0046320) | 2.71887443 |
| 147 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.71883467 |
| 148 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.71000996 |
| 149 | positive T cell selection (GO:0043368) | 2.69973648 |
| 150 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.69817264 |
| 151 | synaptic vesicle exocytosis (GO:0016079) | 2.69516964 |
| 152 | oxaloacetate metabolic process (GO:0006107) | 2.68804083 |
| 153 | locomotory exploration behavior (GO:0035641) | 2.68025701 |
| 154 | stress fiber assembly (GO:0043149) | 2.67242267 |
| 155 | low-density lipoprotein particle clearance (GO:0034383) | 2.62582331 |
| 156 | actin filament capping (GO:0051693) | 2.61393500 |
| 157 | tricarboxylic acid metabolic process (GO:0072350) | 2.60838636 |
| 158 | negative regulation of protein polymerization (GO:0032272) | 2.59130799 |
| 159 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.58619161 |
| 160 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.58223653 |
| 161 | NADH metabolic process (GO:0006734) | 2.58222498 |
| 162 | sarcomere organization (GO:0045214) | 2.57997356 |
| 163 | membrane repolarization (GO:0086009) | 2.57382256 |
| 164 | 2-oxoglutarate metabolic process (GO:0006103) | 2.54504541 |
| 165 | membrane depolarization during action potential (GO:0086010) | 2.53769895 |
| 166 | negative regulation of actin filament polymerization (GO:0030837) | 2.52314832 |
| 167 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.52304092 |
| 168 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.49342191 |
| 169 | pentose-phosphate shunt (GO:0006098) | 2.47842431 |
| 170 | antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886) | 2.47619213 |
| 171 | neurofilament cytoskeleton organization (GO:0060052) | 2.46966625 |
| 172 | regulation of synaptic vesicle transport (GO:1902803) | 2.46860539 |
| 173 | regulation of membrane repolarization (GO:0060306) | 2.43095844 |
| 174 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.42278181 |
| 175 | antigen processing and presentation of peptide antigen via MHC class II (GO:0002495) | 2.42070210 |
| 176 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:000250 | 2.42070210 |
| 177 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.39273168 |
| 178 | cellular potassium ion homeostasis (GO:0030007) | 2.38187742 |
| 179 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.34062570 |
| 180 | alpha-linolenic acid metabolic process (GO:0036109) | 2.33519849 |
| 181 | cardiac muscle contraction (GO:0060048) | 2.33003861 |
| 182 | mitochondrion transport along microtubule (GO:0047497) | 2.32417883 |
| 183 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.32417883 |
| 184 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.31379809 |
| 185 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.31379809 |
| 186 | negative regulation of fatty acid transport (GO:2000192) | 2.30162981 |
| 187 | potassium ion export (GO:0071435) | 2.30101149 |
| 188 | regulation of cholesterol storage (GO:0010885) | 2.30072664 |
| 189 | carnitine transmembrane transport (GO:1902603) | 2.29277108 |
| 190 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.28191285 |
| 191 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.28159214 |
| 192 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.28159214 |
| 193 | NADPH regeneration (GO:0006740) | 2.27715751 |
| 194 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.27490312 |
| 195 | positive regulation of vesicle fusion (GO:0031340) | 2.26145933 |
| 196 | neurotransmitter secretion (GO:0007269) | 2.25836638 |
| 197 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.24675734 |
| 198 | apoptotic cell clearance (GO:0043277) | 2.24664689 |
| 199 | cardiac myofibril assembly (GO:0055003) | 2.24145110 |
| 200 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.23886635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.40237865 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.36363589 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.25974876 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.08521914 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.97596714 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.80408631 |
| 7 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.63383624 |
| 8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.58310302 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.56088654 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.54374831 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.51092725 |
| 12 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.51082570 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.47916356 |
| 14 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.44421168 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.39331601 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.38747267 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32548620 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.31256174 |
| 19 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.26308713 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.23553317 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22868070 |
| 22 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.17292263 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.16241965 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.12301109 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.12121857 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.12005840 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.11724358 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.10288529 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05191387 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.03062333 |
| 31 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.02877606 |
| 32 | KDM2B_26808549_Chip-Seq_K562_Human | 1.96912400 |
| 33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.96373451 |
| 34 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.93852535 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.93539513 |
| 36 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.93360948 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.91717602 |
| 38 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.89370347 |
| 39 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.87048821 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86220424 |
| 41 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.84921993 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81137880 |
| 43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.80964850 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78305640 |
| 45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.78293189 |
| 46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.71682795 |
| 47 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.68762507 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.67497033 |
| 49 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.66861461 |
| 50 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.66350618 |
| 51 | * MYB_26560356_Chip-Seq_TH2_Human | 1.61121787 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.60707318 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.60234672 |
| 54 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.58680177 |
| 55 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.58155434 |
| 56 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57130416 |
| 57 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.56073444 |
| 58 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.55741769 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.55405132 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.54058987 |
| 61 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.52893727 |
| 62 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52357211 |
| 63 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51278877 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.50285062 |
| 65 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.49582054 |
| 66 | ATF3_27146783_Chip-Seq_COLON_Human | 1.48948317 |
| 67 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.48372825 |
| 68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.47706963 |
| 69 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47688287 |
| 70 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.46028621 |
| 71 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.45640852 |
| 72 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.45253075 |
| 73 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.44546032 |
| 74 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.43044809 |
| 75 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42738264 |
| 76 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.40726949 |
| 77 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.39802935 |
| 78 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.39771643 |
| 79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.39368259 |
| 80 | P68_20966046_ChIP-Seq_HELA_Human | 1.39107323 |
| 81 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.37922063 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36784896 |
| 83 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36181019 |
| 84 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.35591775 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35325318 |
| 86 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.34280681 |
| 87 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34153167 |
| 88 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34013634 |
| 89 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.33237679 |
| 90 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32414084 |
| 91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31242863 |
| 92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.30642310 |
| 93 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.29657639 |
| 94 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26932953 |
| 95 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.26757462 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.24825479 |
| 97 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.24191516 |
| 98 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.23744335 |
| 99 | MYC_22102868_ChIP-Seq_BL_Human | 1.22306962 |
| 100 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21158642 |
| 101 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.20903880 |
| 102 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.20780130 |
| 103 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20778544 |
| 104 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20583398 |
| 105 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.20017223 |
| 106 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.19699009 |
| 107 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.19224475 |
| 108 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18953640 |
| 109 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.18880144 |
| 110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18814297 |
| 111 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18332053 |
| 112 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17650243 |
| 113 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.17320633 |
| 114 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.17035076 |
| 115 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.17035076 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16430402 |
| 117 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15561192 |
| 118 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15076969 |
| 119 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.14549319 |
| 120 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.13274872 |
| 121 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13085047 |
| 122 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.13079880 |
| 123 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12554653 |
| 124 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12474327 |
| 125 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.11689961 |
| 126 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11525995 |
| 127 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.11350546 |
| 128 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.11153017 |
| 129 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09658711 |
| 130 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09452237 |
| 131 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09358930 |
| 132 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07791046 |
| 133 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.07688012 |
| 134 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07562184 |
| 135 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06950689 |
| 136 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.05951349 |
| 137 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04739952 |
| 138 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.03182915 |
| 139 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.02955971 |
| 140 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02900060 |
| 141 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02656899 |
| 142 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02341117 |
| 143 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01313453 |
| 144 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.00481403 |
| 145 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99948265 |
| 146 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.99283596 |
| 147 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.98853791 |
| 148 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.98664278 |
| 149 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.98356662 |
| 150 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.98022836 |
| 151 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.98022836 |
| 152 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.97242900 |
| 153 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95417040 |
| 154 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.95191830 |
| 155 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.95016027 |
| 156 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.94613044 |
| 157 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.94166603 |
| 158 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.93927961 |
| 159 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.93816786 |
| 160 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93142844 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.48091783 |
| 2 | MP0004858_abnormal_nervous_system | 4.47823617 |
| 3 | MP0003436_decreased_susceptibility_to | 4.25468395 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.58071073 |
| 5 | MP0002735_abnormal_chemical_nociception | 3.39598096 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.27121246 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 3.15833996 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.04583239 |
| 9 | MP0002419_abnormal_innate_immunity | 3.00891559 |
| 10 | MP0000751_myopathy | 2.96266674 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.90186149 |
| 12 | MP0005025_abnormal_response_to | 2.81861025 |
| 13 | MP0004270_analgesia | 2.76648549 |
| 14 | MP0008260_abnormal_autophagy | 2.65444210 |
| 15 | MP0009278_abnormal_bone_marrow | 2.59779412 |
| 16 | MP0001800_abnormal_humoral_immune | 2.59775576 |
| 17 | MP0005387_immune_system_phenotype | 2.58680550 |
| 18 | MP0001790_abnormal_immune_system | 2.58680550 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.54856912 |
| 20 | MP0002736_abnormal_nociception_after | 2.53678974 |
| 21 | MP0005671_abnormal_response_to | 2.49392391 |
| 22 | MP0000685_abnormal_immune_system | 2.48194788 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.43758430 |
| 24 | MP0002733_abnormal_thermal_nociception | 2.42153123 |
| 25 | MP0001819_abnormal_immune_cell | 2.41154242 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.36712254 |
| 27 | MP0009785_altered_susceptibility_to | 2.35572532 |
| 28 | MP0002723_abnormal_immune_serum | 2.35418108 |
| 29 | MP0002132_abnormal_respiratory_system | 2.33942823 |
| 30 | MP0003329_amyloid_beta_deposits | 2.32775197 |
| 31 | MP0003763_abnormal_thymus_physiology | 2.31932424 |
| 32 | MP0002452_abnormal_antigen_presenting | 2.28146043 |
| 33 | MP0004130_abnormal_muscle_cell | 2.22372547 |
| 34 | MP0005451_abnormal_body_composition | 2.19606500 |
| 35 | MP0004084_abnormal_cardiac_muscle | 2.19242057 |
| 36 | MP0000749_muscle_degeneration | 2.11712715 |
| 37 | MP0002398_abnormal_bone_marrow | 2.04512526 |
| 38 | MP0000465_gastrointestinal_hemorrhage | 2.01505155 |
| 39 | MP0001533_abnormal_skeleton_physiology | 2.00209622 |
| 40 | MP0008438_abnormal_cutaneous_collagen | 1.99138533 |
| 41 | MP0002396_abnormal_hematopoietic_system | 1.96163606 |
| 42 | MP0006082_CNS_inflammation | 1.95203501 |
| 43 | MP0002734_abnormal_mechanical_nocicepti | 1.94915068 |
| 44 | MP0002405_respiratory_system_inflammati | 1.91062469 |
| 45 | MP0000716_abnormal_immune_system | 1.87664199 |
| 46 | MP0001970_abnormal_pain_threshold | 1.87374245 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.86387713 |
| 48 | MP0004087_abnormal_muscle_fiber | 1.80540039 |
| 49 | MP0003566_abnormal_cell_adhesion | 1.78989068 |
| 50 | MP0003279_aneurysm | 1.77927765 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.74940460 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.74669422 |
| 53 | MP0002269_muscular_atrophy | 1.73584448 |
| 54 | MP0009840_abnormal_foam_cell | 1.72050099 |
| 55 | MP0010155_abnormal_intestine_physiology | 1.71144969 |
| 56 | MP0004947_skin_inflammation | 1.70257571 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.70081547 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.70081547 |
| 59 | MP0002722_abnormal_immune_system | 1.69236209 |
| 60 | MP0005083_abnormal_biliary_tract | 1.66452276 |
| 61 | MP0004036_abnormal_muscle_relaxation | 1.65234945 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.64155009 |
| 63 | MP0000858_altered_metastatic_potential | 1.63442137 |
| 64 | MP0000747_muscle_weakness | 1.62693693 |
| 65 | MP0000604_amyloidosis | 1.62463395 |
| 66 | MP0000703_abnormal_thymus_morphology | 1.60776870 |
| 67 | MP0003828_pulmonary_edema | 1.60098026 |
| 68 | MP0002429_abnormal_blood_cell | 1.58309610 |
| 69 | MP0000013_abnormal_adipose_tissue | 1.51736867 |
| 70 | MP0001845_abnormal_inflammatory_respons | 1.51545930 |
| 71 | MP0003866_abnormal_defecation | 1.50694607 |
| 72 | MP0003646_muscle_fatigue | 1.47807482 |
| 73 | MP0003635_abnormal_synaptic_transmissio | 1.44710329 |
| 74 | MP0003183_abnormal_peptide_metabolism | 1.44195795 |
| 75 | MP0004510_myositis | 1.43209276 |
| 76 | MP0004381_abnormal_hair_follicle | 1.43017609 |
| 77 | MP0004215_abnormal_myocardial_fiber | 1.41965390 |
| 78 | MP0002972_abnormal_cardiac_muscle | 1.40807182 |
| 79 | MP0000759_abnormal_skeletal_muscle | 1.40292132 |
| 80 | MP0001851_eye_inflammation | 1.39689336 |
| 81 | MP0006276_abnormal_autonomic_nervous | 1.39125795 |
| 82 | MP0003172_abnormal_lysosome_physiology | 1.39108422 |
| 83 | MP0004811_abnormal_neuron_physiology | 1.38618486 |
| 84 | MP0008961_abnormal_basal_metabolism | 1.38115304 |
| 85 | MP0005330_cardiomyopathy | 1.37510945 |
| 86 | MP0008775_abnormal_heart_ventricle | 1.30383520 |
| 87 | MP0008469_abnormal_protein_level | 1.29896727 |
| 88 | MP0000750_abnormal_muscle_regeneration | 1.28279597 |
| 89 | MP0001958_emphysema | 1.26872082 |
| 90 | MP0003075_altered_response_to | 1.24957626 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 1.23789497 |
| 92 | MP0009780_abnormal_chondrocyte_physiolo | 1.23714936 |
| 93 | MP0003303_peritoneal_inflammation | 1.23417859 |
| 94 | MP0003221_abnormal_cardiomyocyte_apopto | 1.22192126 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 1.21596916 |
| 96 | MP0001849_ear_inflammation | 1.19636259 |
| 97 | MP0005620_abnormal_muscle_contractility | 1.19301946 |
| 98 | MP0005385_cardiovascular_system_phenoty | 1.17499366 |
| 99 | MP0001544_abnormal_cardiovascular_syste | 1.17499366 |
| 100 | MP0005275_abnormal_skin_tensile | 1.15825156 |
| 101 | MP0000343_altered_response_to | 1.13631615 |
| 102 | MP0001348_abnormal_lacrimal_gland | 1.12929382 |
| 103 | MP0004233_abnormal_muscle_weight | 1.12836736 |
| 104 | MP0010630_abnormal_cardiac_muscle | 1.12801825 |
| 105 | MP0010329_abnormal_lipoprotein_level | 1.11091711 |
| 106 | MP0003633_abnormal_nervous_system | 1.08104556 |
| 107 | MP0002106_abnormal_muscle_physiology | 1.07094811 |
| 108 | MP0003300_gastrointestinal_ulcer | 1.06223333 |
| 109 | MP0000490_abnormal_crypts_of | 1.06150008 |
| 110 | MP0005623_abnormal_meninges_morphology | 1.05520772 |
| 111 | MP0005167_abnormal_blood-brain_barrier | 1.04260633 |
| 112 | MP0003806_abnormal_nucleotide_metabolis | 1.01490108 |
| 113 | MP0004145_abnormal_muscle_electrophysio | 1.00411585 |
| 114 | MP0005670_abnormal_white_adipose | 0.99935930 |
| 115 | MP0009764_decreased_sensitivity_to | 0.99233823 |
| 116 | MP0003690_abnormal_glial_cell | 0.98829765 |
| 117 | MP0002998_abnormal_bone_remodeling | 0.96477181 |
| 118 | MP0010352_gastrointestinal_tract_polyps | 0.94852213 |
| 119 | MP0008004_abnormal_stomach_pH | 0.94404837 |
| 120 | MP0002063_abnormal_learning/memory/cond | 0.94381669 |
| 121 | MP0003191_abnormal_cellular_cholesterol | 0.92836060 |
| 122 | MP0006138_congestive_heart_failure | 0.92201203 |
| 123 | MP0001873_stomach_inflammation | 0.91321524 |
| 124 | MP0002184_abnormal_innervation | 0.91283968 |
| 125 | MP0005310_abnormal_salivary_gland | 0.90994173 |
| 126 | MP0008874_decreased_physiological_sensi | 0.90189645 |
| 127 | MP0005076_abnormal_cell_differentiation | 0.89767091 |
| 128 | MP0002139_abnormal_hepatobiliary_system | 0.88754414 |
| 129 | MP0005023_abnormal_wound_healing | 0.88598736 |
| 130 | MP0005058_abnormal_lysosome_morphology | 0.88393839 |
| 131 | MP0005666_abnormal_adipose_tissue | 0.88020654 |
| 132 | MP0004085_abnormal_heartbeat | 0.86854743 |
| 133 | MP0002822_catalepsy | 0.85962705 |
| 134 | MP0003878_abnormal_ear_physiology | 0.85391741 |
| 135 | MP0005377_hearing/vestibular/ear_phenot | 0.85391741 |
| 136 | MP0005365_abnormal_bile_salt | 0.85122244 |
| 137 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.84870171 |
| 138 | MP0005319_abnormal_enzyme/_coenzyme | 0.84805424 |
| 139 | MP0005390_skeleton_phenotype | 0.84755670 |
| 140 | MP0005369_muscle_phenotype | 0.83636621 |
| 141 | MP0001756_abnormal_urination | 0.83033987 |
| 142 | MP0000003_abnormal_adipose_tissue | 0.82161914 |
| 143 | MP0004808_abnormal_hematopoietic_stem | 0.82149054 |
| 144 | MP0004883_abnormal_blood_vessel | 0.81339211 |
| 145 | MP0005375_adipose_tissue_phenotype | 0.81167681 |
| 146 | MP0002166_altered_tumor_susceptibility | 0.80184862 |
| 147 | MP0000955_abnormal_spinal_cord | 0.80032613 |
| 148 | MP0003091_abnormal_cell_migration | 0.79796089 |
| 149 | MP0002118_abnormal_lipid_homeostasis | 0.79653620 |
| 150 | MP0002089_abnormal_postnatal_growth/wei | 0.79551535 |
| 151 | MP0005535_abnormal_body_temperature | 0.78343724 |
| 152 | MP0005164_abnormal_response_to | 0.78054919 |
| 153 | MP0009763_increased_sensitivity_to | 0.77063743 |
| 154 | MP0000358_abnormal_cell_content/ | 0.76121513 |
| 155 | MP0001853_heart_inflammation | 0.74868785 |
| 156 | MP0002078_abnormal_glucose_homeostasis | 0.74849243 |
| 157 | MP0006036_abnormal_mitochondrial_physio | 0.74706819 |
| 158 | MP0004185_abnormal_adipocyte_glucose | 0.74539025 |
| 159 | MP0001663_abnormal_digestive_system | 0.74375689 |
| 160 | MP0003137_abnormal_impulse_conducting | 0.74337752 |
| 161 | MP0002064_seizures | 0.74079992 |
| 162 | MP0000534_abnormal_ureter_morphology | 0.72409709 |
| 163 | MP0005166_decreased_susceptibility_to | 0.72304795 |
| 164 | MP0000678_abnormal_parathyroid_gland | 0.71809465 |
| 165 | MP0003631_nervous_system_phenotype | 0.70822533 |
| 166 | MP0002877_abnormal_melanocyte_morpholog | 0.69996072 |
| 167 | MP0008569_lethality_at_weaning | 0.69087819 |
| 168 | MP0003448_altered_tumor_morphology | 0.65088610 |
| 169 | MP0002933_joint_inflammation | 0.63338775 |
| 170 | MP0005075_abnormal_melanosome_morpholog | 0.62837233 |
| 171 | MP0004264_abnormal_extraembryonic_tissu | 0.62653222 |
| 172 | MP0002653_abnormal_ependyma_morphology | 0.60809410 |
| 173 | MP0002019_abnormal_tumor_incidence | 0.58963706 |
| 174 | MP0003795_abnormal_bone_structure | 0.57341786 |
| 175 | MP0009765_abnormal_xenobiotic_induced | 0.55979959 |
| 176 | MP0001915_intracranial_hemorrhage | 0.54564267 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.72217432 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.54641005 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.28168212 |
| 4 | Myositis (HP:0100614) | 5.08259801 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.06207813 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.54509801 |
| 7 | Orchitis (HP:0100796) | 4.48522312 |
| 8 | Chronic obstructive pulmonary disease (HP:0006510) | 4.44254172 |
| 9 | Obstructive lung disease (HP:0006536) | 4.44254172 |
| 10 | Stomatitis (HP:0010280) | 4.03379205 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.02148386 |
| 12 | Optic neuritis (HP:0100653) | 3.87634773 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 3.87634773 |
| 14 | Meningitis (HP:0001287) | 3.85558123 |
| 15 | Myokymia (HP:0002411) | 3.84362466 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 3.84129476 |
| 17 | Increased IgE level (HP:0003212) | 3.82743271 |
| 18 | Cellulitis (HP:0100658) | 3.79279848 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.78810537 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 3.77606888 |
| 21 | Hypochromic microcytic anemia (HP:0004840) | 3.72978661 |
| 22 | Prolonged bleeding time (HP:0003010) | 3.66891308 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.47210157 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.47057243 |
| 25 | Recurrent skin infections (HP:0001581) | 3.40492470 |
| 26 | Myotonia (HP:0002486) | 3.34008056 |
| 27 | Gingivitis (HP:0000230) | 3.32635240 |
| 28 | Urticaria (HP:0001025) | 3.29200458 |
| 29 | Hypochromic anemia (HP:0001931) | 3.27540968 |
| 30 | Pheochromocytoma (HP:0002666) | 3.26979301 |
| 31 | Encephalitis (HP:0002383) | 3.10818696 |
| 32 | Sudden death (HP:0001699) | 3.08222900 |
| 33 | Abnormality of the lower motor neuron (HP:0002366) | 3.06689851 |
| 34 | Gastrointestinal inflammation (HP:0004386) | 3.06335404 |
| 35 | Chest pain (HP:0100749) | 3.01021103 |
| 36 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.97551656 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 2.97443796 |
| 38 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.97443796 |
| 39 | Neuroendocrine neoplasm (HP:0100634) | 2.92604742 |
| 40 | Hyporeflexia of lower limbs (HP:0002600) | 2.92583708 |
| 41 | Abnormality of pain sensation (HP:0010832) | 2.92369003 |
| 42 | Impaired pain sensation (HP:0007328) | 2.92369003 |
| 43 | Petechiae (HP:0000967) | 2.91753465 |
| 44 | Hand muscle atrophy (HP:0009130) | 2.90704608 |
| 45 | Inflammation of the large intestine (HP:0002037) | 2.90193058 |
| 46 | Protrusio acetabuli (HP:0003179) | 2.89825775 |
| 47 | Keratoconjunctivitis sicca (HP:0001097) | 2.89078216 |
| 48 | Upper limb amyotrophy (HP:0009129) | 2.88557861 |
| 49 | Distal upper limb amyotrophy (HP:0007149) | 2.88557861 |
| 50 | Episodic fever (HP:0001954) | 2.88429825 |
| 51 | Hypercortisolism (HP:0001578) | 2.87977246 |
| 52 | Asymmetric septal hypertrophy (HP:0001670) | 2.87740357 |
| 53 | Epistaxis (HP:0000421) | 2.86662239 |
| 54 | Myoglobinuria (HP:0002913) | 2.84772367 |
| 55 | Action tremor (HP:0002345) | 2.84498406 |
| 56 | Vasculitis (HP:0002633) | 2.83602279 |
| 57 | Increased connective tissue (HP:0009025) | 2.79997004 |
| 58 | Panhypogammaglobulinemia (HP:0003139) | 2.73473822 |
| 59 | Gingival bleeding (HP:0000225) | 2.71861232 |
| 60 | Ulnar claw (HP:0001178) | 2.59945954 |
| 61 | Recurrent viral infections (HP:0004429) | 2.59655696 |
| 62 | Exercise-induced muscle cramps (HP:0003710) | 2.58781296 |
| 63 | Cerebral aneurysm (HP:0004944) | 2.56599446 |
| 64 | Keratoconjunctivitis (HP:0001096) | 2.55946736 |
| 65 | Osteomyelitis (HP:0002754) | 2.55854115 |
| 66 | Amyloidosis (HP:0011034) | 2.54408918 |
| 67 | Agammaglobulinemia (HP:0004432) | 2.53037682 |
| 68 | Polycythemia (HP:0001901) | 2.50661805 |
| 69 | Difficulty running (HP:0009046) | 2.50227305 |
| 70 | Sepsis (HP:0100806) | 2.48987144 |
| 71 | Colitis (HP:0002583) | 2.48562711 |
| 72 | Difficulty climbing stairs (HP:0003551) | 2.47458730 |
| 73 | Pustule (HP:0200039) | 2.46204390 |
| 74 | Termporal pattern (HP:0011008) | 2.46068286 |
| 75 | Insidious onset (HP:0003587) | 2.46068286 |
| 76 | Increased variability in muscle fiber diameter (HP:0003557) | 2.44300625 |
| 77 | Exercise-induced myalgia (HP:0003738) | 2.44037994 |
| 78 | Microcytic anemia (HP:0001935) | 2.43999764 |
| 79 | Purpura (HP:0000979) | 2.43139972 |
| 80 | Palpitations (HP:0001962) | 2.42631931 |
| 81 | Achilles tendon contracture (HP:0001771) | 2.40549000 |
| 82 | Bundle branch block (HP:0011710) | 2.40244001 |
| 83 | Abnormality of the vocal cords (HP:0008777) | 2.39813462 |
| 84 | Arterial thrombosis (HP:0004420) | 2.36938292 |
| 85 | Granulocytopenia (HP:0001913) | 2.36351567 |
| 86 | Anorexia (HP:0002039) | 2.35996524 |
| 87 | Abnormality of the Achilles tendon (HP:0005109) | 2.35472716 |
| 88 | Leukocytosis (HP:0001974) | 2.34033476 |
| 89 | Metaphyseal cupping (HP:0003021) | 2.33608066 |
| 90 | Long toe (HP:0010511) | 2.33116288 |
| 91 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.33022540 |
| 92 | Abnormal platelet volume (HP:0011876) | 2.32716324 |
| 93 | Ventricular fibrillation (HP:0001663) | 2.32371325 |
| 94 | Visual hallucinations (HP:0002367) | 2.31007828 |
| 95 | Hypertensive crisis (HP:0100735) | 2.30727828 |
| 96 | Hemoptysis (HP:0002105) | 2.29168688 |
| 97 | Muscle stiffness (HP:0003552) | 2.29013341 |
| 98 | Increased IgM level (HP:0003496) | 2.27436708 |
| 99 | Pulmonary embolism (HP:0002204) | 2.25266968 |
| 100 | Hepatosplenomegaly (HP:0001433) | 2.24455254 |
| 101 | Pulmonary infiltrates (HP:0002113) | 2.23223796 |
| 102 | Polygenic inheritance (HP:0010982) | 2.22482444 |
| 103 | EMG: myopathic abnormalities (HP:0003458) | 2.20815157 |
| 104 | Foot dorsiflexor weakness (HP:0009027) | 2.19826516 |
| 105 | Distal arthrogryposis (HP:0005684) | 2.19788230 |
| 106 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.19622074 |
| 107 | Abnormality of the peritoneum (HP:0002585) | 2.18886634 |
| 108 | Supranuclear gaze palsy (HP:0000605) | 2.18563348 |
| 109 | Striae distensae (HP:0001065) | 2.18267285 |
| 110 | Neonatal onset (HP:0003623) | 2.17171549 |
| 111 | Type 1 muscle fiber predominance (HP:0003803) | 2.14055756 |
| 112 | Hypoventilation (HP:0002791) | 2.13325152 |
| 113 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.12935708 |
| 114 | Lymphopenia (HP:0001888) | 2.11619870 |
| 115 | Ventricular tachycardia (HP:0004756) | 2.11219894 |
| 116 | Skin ulcer (HP:0200042) | 2.11137137 |
| 117 | Rapidly progressive (HP:0003678) | 2.10715116 |
| 118 | Abnormal gallbladder physiology (HP:0012438) | 2.09977794 |
| 119 | Cholecystitis (HP:0001082) | 2.09977794 |
| 120 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.09628125 |
| 121 | Hammertoe (HP:0001765) | 2.09554771 |
| 122 | Hypergammaglobulinemia (HP:0010702) | 2.08513873 |
| 123 | Increased serum ferritin (HP:0003281) | 2.05542305 |
| 124 | T lymphocytopenia (HP:0005403) | 2.05217300 |
| 125 | Ankle clonus (HP:0011448) | 2.04959087 |
| 126 | Slow saccadic eye movements (HP:0000514) | 2.04541787 |
| 127 | Broad metatarsal (HP:0001783) | 2.03322668 |
| 128 | Ankle contracture (HP:0006466) | 2.03216487 |
| 129 | Premature loss of primary teeth (HP:0006323) | 2.02814596 |
| 130 | Torticollis (HP:0000473) | 2.02647560 |
| 131 | Abnormality of T cells (HP:0002843) | 2.01928717 |
| 132 | Enlarged penis (HP:0000040) | 2.01821398 |
| 133 | Abnormality of the foot musculature (HP:0001436) | 2.01525508 |
| 134 | Oligomenorrhea (HP:0000876) | 2.01505824 |
| 135 | Muscle fiber splitting (HP:0003555) | 2.01473373 |
| 136 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.98862707 |
| 137 | Deep venous thrombosis (HP:0002625) | 1.98846444 |
| 138 | Viral hepatitis (HP:0006562) | 1.98351022 |
| 139 | EMG: neuropathic changes (HP:0003445) | 1.95948742 |
| 140 | Papilledema (HP:0001085) | 1.94303173 |
| 141 | Acne (HP:0001061) | 1.93278956 |
| 142 | Interstitial pulmonary disease (HP:0006530) | 1.93244632 |
| 143 | Growth hormone excess (HP:0000845) | 1.92242950 |
| 144 | Hyperacusis (HP:0010780) | 1.90843245 |
| 145 | Lymphangioma (HP:0100764) | 1.90077874 |
| 146 | Papilloma (HP:0012740) | 1.89231905 |
| 147 | Verrucae (HP:0200043) | 1.89231905 |
| 148 | Rhabdomyolysis (HP:0003201) | 1.89167073 |
| 149 | Bowel diverticulosis (HP:0005222) | 1.89062464 |
| 150 | Abnormality of iron homeostasis (HP:0011031) | 1.89000424 |
| 151 | Peritonitis (HP:0002586) | 1.88952402 |
| 152 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.88578944 |
| 153 | Conjunctival hamartoma (HP:0100780) | 1.87958304 |
| 154 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.87932734 |
| 155 | Increased cerebral lipofuscin (HP:0011813) | 1.87843598 |
| 156 | Insomnia (HP:0100785) | 1.87177547 |
| 157 | Right ventricular cardiomyopathy (HP:0011663) | 1.86076254 |
| 158 | Abnormal hemoglobin (HP:0011902) | 1.86076191 |
| 159 | Abnormality of T cell number (HP:0011839) | 1.84555487 |
| 160 | Depression (HP:0000716) | 1.84389081 |
| 161 | Loss of speech (HP:0002371) | 1.84276250 |
| 162 | Hypermelanotic macule (HP:0001034) | 1.84243194 |
| 163 | Limb-girdle muscle atrophy (HP:0003797) | 1.84020063 |
| 164 | Craniofacial dystonia (HP:0012179) | 1.82865489 |
| 165 | Gastrointestinal dysmotility (HP:0002579) | 1.82837728 |
| 166 | Neoplasm of the adrenal gland (HP:0100631) | 1.82788702 |
| 167 | Frequent falls (HP:0002359) | 1.82500599 |
| 168 | Skin rash (HP:0000988) | 1.82135956 |
| 169 | Abnormality of the pleura (HP:0002103) | 1.81703207 |
| 170 | Hypertriglyceridemia (HP:0002155) | 1.80666620 |
| 171 | Nasal polyposis (HP:0100582) | 1.80211907 |
| 172 | Failure to thrive in infancy (HP:0001531) | 1.79786122 |
| 173 | Acute hepatic failure (HP:0006554) | 1.79606125 |
| 174 | Abnormality of T cell physiology (HP:0011840) | 1.79116354 |
| 175 | Resting tremor (HP:0002322) | 1.78949142 |
| 176 | Ventricular arrhythmia (HP:0004308) | 1.77532429 |
| 177 | Urinary urgency (HP:0000012) | 1.77503032 |
| 178 | Ketoacidosis (HP:0001993) | 1.76450774 |
| 179 | Focal seizures (HP:0007359) | 1.76098836 |
| 180 | Vertebral compression fractures (HP:0002953) | 1.75020931 |
| 181 | Focal dystonia (HP:0004373) | 1.74172029 |
| 182 | Primary atrial arrhythmia (HP:0001692) | 1.72972245 |
| 183 | Cholelithiasis (HP:0001081) | 1.71474630 |
| 184 | Dysmetric saccades (HP:0000641) | 1.70874518 |
| 185 | Spinal canal stenosis (HP:0003416) | 1.70033665 |
| 186 | Wrist flexion contracture (HP:0001239) | 1.69200111 |
| 187 | Lipoatrophy (HP:0100578) | 1.68646414 |
| 188 | Atrial fibrillation (HP:0005110) | 1.67178771 |
| 189 | Axonal loss (HP:0003447) | 1.67172676 |
| 190 | Supraventricular arrhythmia (HP:0005115) | 1.67020489 |
| 191 | Athetosis (HP:0002305) | 1.66449484 |
| 192 | Hamartoma of the eye (HP:0010568) | 1.66437693 |
| 193 | Supraventricular tachycardia (HP:0004755) | 1.65866911 |
| 194 | Aneurysm (HP:0002617) | 1.65321132 |
| 195 | Bladder diverticulum (HP:0000015) | 1.65071103 |
| 196 | Shallow orbits (HP:0000586) | 1.64989403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.17904790 |
| 2 | MAP4K1 | 3.69960854 |
| 3 | PKN2 | 3.03497550 |
| 4 | MAP3K9 | 2.85870747 |
| 5 | KSR2 | 2.82382492 |
| 6 | NTRK1 | 2.79701163 |
| 7 | NEK1 | 2.65378248 |
| 8 | FES | 2.62691602 |
| 9 | IRAK4 | 2.61447753 |
| 10 | PRPF4B | 2.59725383 |
| 11 | RIPK1 | 2.53812847 |
| 12 | TYK2 | 2.51253809 |
| 13 | TNK2 | 2.51179167 |
| 14 | TTN | 2.41602786 |
| 15 | LMTK2 | 2.32539426 |
| 16 | GRK6 | 2.30518132 |
| 17 | MINK1 | 2.29158793 |
| 18 | CSK | 2.22027140 |
| 19 | ERN1 | 2.19179691 |
| 20 | LATS2 | 2.18451152 |
| 21 | SMG1 | 2.11565284 |
| 22 | LIMK1 | 1.98426278 |
| 23 | DAPK2 | 1.97520171 |
| 24 | ZAP70 | 1.94354850 |
| 25 | PHKG2 | 1.91404824 |
| 26 | PHKG1 | 1.91404824 |
| 27 | TESK1 | 1.81293949 |
| 28 | PRKD3 | 1.79971592 |
| 29 | MAP3K3 | 1.79855940 |
| 30 | ARAF | 1.73197862 |
| 31 | MAP3K2 | 1.71722585 |
| 32 | PAK6 | 1.70728143 |
| 33 | JAK3 | 1.70404647 |
| 34 | CAMKK1 | 1.67993370 |
| 35 | BTK | 1.66225374 |
| 36 | RET | 1.65550169 |
| 37 | HCK | 1.58211713 |
| 38 | SIK3 | 1.52270825 |
| 39 | SCYL2 | 1.51659579 |
| 40 | PDGFRA | 1.49809161 |
| 41 | MAPKAPK3 | 1.42095798 |
| 42 | MAP3K13 | 1.38242591 |
| 43 | NTRK3 | 1.35660171 |
| 44 | GRK5 | 1.35600206 |
| 45 | PRKD2 | 1.33607120 |
| 46 | FGR | 1.30792833 |
| 47 | MARK2 | 1.29986998 |
| 48 | MAP2K4 | 1.27552767 |
| 49 | SYK | 1.22941365 |
| 50 | TBK1 | 1.22431194 |
| 51 | TAOK1 | 1.19924623 |
| 52 | MAP2K1 | 1.19351776 |
| 53 | STK10 | 1.14412428 |
| 54 | MAP3K12 | 1.14179630 |
| 55 | MATK | 1.10419727 |
| 56 | MAP3K1 | 1.07741525 |
| 57 | PTK2 | 1.07162810 |
| 58 | RPS6KA2 | 1.06479169 |
| 59 | LYN | 1.06218763 |
| 60 | MAP3K11 | 1.03124639 |
| 61 | CAMKK2 | 1.02204231 |
| 62 | DAPK1 | 0.98198704 |
| 63 | TAOK2 | 0.97665768 |
| 64 | MARK1 | 0.97588351 |
| 65 | LCK | 0.96760291 |
| 66 | TESK2 | 0.96254778 |
| 67 | PTK6 | 0.95230588 |
| 68 | SIK2 | 0.95003384 |
| 69 | IKBKE | 0.94149152 |
| 70 | MAP3K14 | 0.93918622 |
| 71 | LRRK2 | 0.92807289 |
| 72 | EEF2K | 0.92276449 |
| 73 | PDK3 | 0.91987872 |
| 74 | PDK4 | 0.91987872 |
| 75 | MAP3K4 | 0.91507024 |
| 76 | CSF1R | 0.90989152 |
| 77 | TXK | 0.90971490 |
| 78 | STK38 | 0.90608126 |
| 79 | PTK2B | 0.89952743 |
| 80 | MAP3K6 | 0.88837282 |
| 81 | YES1 | 0.88597922 |
| 82 | DAPK3 | 0.88404022 |
| 83 | BCKDK | 0.87374119 |
| 84 | PAK3 | 0.85177417 |
| 85 | ITK | 0.83848138 |
| 86 | MAP3K7 | 0.83218607 |
| 87 | DYRK1B | 0.82712250 |
| 88 | MYLK | 0.81548104 |
| 89 | FER | 0.81546532 |
| 90 | ICK | 0.81365816 |
| 91 | CDK19 | 0.80858183 |
| 92 | CAMK1D | 0.78490457 |
| 93 | DMPK | 0.72738072 |
| 94 | CDK12 | 0.72673522 |
| 95 | MARK3 | 0.72548599 |
| 96 | RIPK4 | 0.71563781 |
| 97 | ILK | 0.70771822 |
| 98 | PRKCH | 0.70247942 |
| 99 | ALK | 0.69873051 |
| 100 | FLT3 | 0.69423312 |
| 101 | HIPK2 | 0.68542481 |
| 102 | IRAK2 | 0.67359979 |
| 103 | MAP2K3 | 0.66237440 |
| 104 | PIM2 | 0.66200951 |
| 105 | FGFR4 | 0.65336543 |
| 106 | MAPK12 | 0.65217727 |
| 107 | CDK14 | 0.64947139 |
| 108 | MAP3K8 | 0.64437229 |
| 109 | * FYN | 0.63208934 |
| 110 | CDK5 | 0.61548441 |
| 111 | SIK1 | 0.60801261 |
| 112 | RPS6KC1 | 0.57261235 |
| 113 | RPS6KL1 | 0.57261235 |
| 114 | BMX | 0.54548593 |
| 115 | CDC42BPA | 0.54526972 |
| 116 | EPHB1 | 0.54370473 |
| 117 | RAF1 | 0.54356542 |
| 118 | SGK3 | 0.53237563 |
| 119 | PDPK1 | 0.53160433 |
| 120 | IRAK1 | 0.52102436 |
| 121 | KSR1 | 0.50513055 |
| 122 | MAP3K5 | 0.49314887 |
| 123 | ROCK1 | 0.49034308 |
| 124 | JAK2 | 0.48938185 |
| 125 | CDK15 | 0.48077290 |
| 126 | PRKG2 | 0.47897846 |
| 127 | STK11 | 0.47393672 |
| 128 | CDK18 | 0.47169340 |
| 129 | DDR2 | 0.47056064 |
| 130 | PDK1 | 0.46650736 |
| 131 | CAMK1G | 0.44847897 |
| 132 | MAP3K10 | 0.44121329 |
| 133 | MAP2K2 | 0.43257986 |
| 134 | TEC | 0.43206777 |
| 135 | KDR | 0.43003308 |
| 136 | PAK4 | 0.42117306 |
| 137 | MAP2K6 | 0.40956053 |
| 138 | UHMK1 | 0.40927781 |
| 139 | CAMK4 | 0.40116897 |
| 140 | CDK11A | 0.39966209 |
| 141 | KIT | 0.39943342 |
| 142 | RPS6KA6 | 0.39066008 |
| 143 | MAPKAPK2 | 0.39051927 |
| 144 | CDK4 | 0.38948004 |
| 145 | BRSK1 | 0.38910106 |
| 146 | FGFR3 | 0.38633613 |
| 147 | MAPK7 | 0.38003849 |
| 148 | EPHA3 | 0.37410797 |
| 149 | PRKCQ | 0.36986455 |
| 150 | STK24 | 0.35618212 |
| 151 | PRKCZ | 0.35567934 |
| 152 | PINK1 | 0.35554473 |
| 153 | IKBKB | 0.34333072 |
| 154 | FGFR1 | 0.33816060 |
| 155 | BLK | 0.32834079 |
| 156 | JAK1 | 0.31914819 |
| 157 | PRKD1 | 0.31548987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.16680502 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.85566286 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.82764392 |
| 4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.59792529 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.58241348 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.54797534 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.44927595 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.42277411 |
| 9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.27465793 |
| 10 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.26848285 |
| 11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.26803394 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.23134826 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.99425184 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.95550683 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.91630258 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.82882005 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.82811117 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.81300042 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.77402618 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.73500710 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.72943965 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.69149712 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.59475006 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.58073935 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.55126794 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.53819790 |
| 27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.51255928 |
| 28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.50475929 |
| 29 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.50085485 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43356605 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.43053718 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43047918 |
| 33 | Olfactory transduction_Homo sapiens_hsa04740 | 1.42483855 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.39811466 |
| 35 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.36093071 |
| 36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.35325851 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.35314821 |
| 38 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.32403442 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32375436 |
| 40 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.31580494 |
| 41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29437706 |
| 42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.27356094 |
| 43 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.27023175 |
| 44 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 1.23361430 |
| 45 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.23053499 |
| 46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.20495963 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.20445785 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.20249004 |
| 49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.20079493 |
| 50 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.19937825 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 1.18371901 |
| 52 | Glioma_Homo sapiens_hsa05214 | 1.17014875 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 1.16533416 |
| 54 | Insulin secretion_Homo sapiens_hsa04911 | 1.15199898 |
| 55 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.12316410 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.12268117 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 1.11836189 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11603286 |
| 59 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.11456621 |
| 60 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.10390886 |
| 61 | Legionellosis_Homo sapiens_hsa05134 | 1.08976612 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 1.07366184 |
| 63 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.06704946 |
| 64 | Bile secretion_Homo sapiens_hsa04976 | 1.05589287 |
| 65 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.05086991 |
| 66 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04855943 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.04572397 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.04481306 |
| 69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.02664791 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.01536462 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.01292451 |
| 72 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.99972853 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.99735846 |
| 74 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.99142372 |
| 75 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.98920403 |
| 76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.97323756 |
| 77 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.96847487 |
| 78 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.95609779 |
| 79 | Gap junction_Homo sapiens_hsa04540 | 0.95089443 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94546572 |
| 81 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93855379 |
| 82 | Bladder cancer_Homo sapiens_hsa05219 | 0.93834851 |
| 83 | Long-term potentiation_Homo sapiens_hsa04720 | 0.93095550 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.92884156 |
| 85 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.92622540 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.92245418 |
| 87 | Apoptosis_Homo sapiens_hsa04210 | 0.92067094 |
| 88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.91512097 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90131914 |
| 90 | Thyroid cancer_Homo sapiens_hsa05216 | 0.89832268 |
| 91 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.89187039 |
| 92 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.88319167 |
| 93 | Circadian entrainment_Homo sapiens_hsa04713 | 0.87585203 |
| 94 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.84654007 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83514556 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.82735074 |
| 97 | Colorectal cancer_Homo sapiens_hsa05210 | 0.82339603 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.81325944 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.81070027 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.79731156 |
| 101 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79240251 |
| 102 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.78395212 |
| 103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.77778207 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.77354411 |
| 105 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.76914437 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76830349 |
| 107 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74683243 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74427942 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.73541053 |
| 110 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.73076321 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72924295 |
| 112 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72477551 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71281088 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.69437159 |
| 115 | Focal adhesion_Homo sapiens_hsa04510 | 0.69157394 |
| 116 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69034561 |
| 117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68635758 |
| 118 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68044520 |
| 119 | Salivary secretion_Homo sapiens_hsa04970 | 0.67923690 |
| 120 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67809627 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66885272 |
| 122 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.66600319 |
| 123 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.65798769 |
| 124 | Asthma_Homo sapiens_hsa05310 | 0.65311984 |
| 125 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64940217 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64896285 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64772220 |
| 128 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64295287 |
| 129 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64193844 |
| 130 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64076772 |
| 131 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64027097 |
| 132 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63901854 |
| 133 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63538095 |
| 134 | Salmonella infection_Homo sapiens_hsa05132 | 0.63436577 |
| 135 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.63168545 |
| 136 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62067136 |
| 137 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61831862 |
| 138 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.61648775 |
| 139 | Lysosome_Homo sapiens_hsa04142 | 0.61540043 |
| 140 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60463413 |
| 141 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59779383 |
| 142 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59508640 |
| 143 | Phagosome_Homo sapiens_hsa04145 | 0.59028066 |
| 144 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58638884 |
| 145 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58129061 |
| 146 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55904028 |
| 147 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55390030 |
| 148 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.54912027 |
| 149 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54592308 |
| 150 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54383107 |
| 151 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54278975 |
| 152 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53450909 |
| 153 | Renin secretion_Homo sapiens_hsa04924 | 0.53299209 |
| 154 | GABAergic synapse_Homo sapiens_hsa04727 | 0.53043226 |
| 155 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.51771161 |
| 156 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50769263 |
| 157 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50629086 |
| 158 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48685671 |
| 159 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48443228 |
| 160 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48161977 |
| 161 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48152708 |
| 162 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.46946276 |
| 163 | Melanogenesis_Homo sapiens_hsa04916 | 0.45089518 |

